Skip to main content
Erschienen in: Heart and Vessels 4/2013

01.07.2013 | Original Article

Serum total bilirubin is inversely associated with brachial-ankle pulse wave velocity in men with hypertension

verfasst von: Zheng-Yun Zhang, Lu-Qin Bian, Sae-Young Jae, Ji-Dong Sung, Yoon-Ho Choi

Erschienen in: Heart and Vessels | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Serum total bilirubin has been suggested to have the potential anti-inflammatory and antioxidant effects on the vasculature. This study was designed to investigate the association of bilirubin with brachial-ankle pulse wave velocity (baPWV), a marker of arterial stiffness and cardiovascular disease. Hypertensive male subjects (n = 2,361) were classified into groups according to the 50th, 75th, and 95th percentiles of baPWV value. Correlation and regression analysis were used to assess the relationship between baPWV and other variables. Hypertensive subjects with baPWV above the 50th, 75th, and 95th percentiles had a significantly lower bilirubin level than those with baPWV under them (0.97 ± 0.40 vs. 1.00 ± 0.41 mg/dl, P < 0.001; 0.95 ± 0.39 vs. 0.99 ± 0.41 mg/dl, P = 0.001; 0.92 ± 0.36 vs. 0.99 ± 0.42 mg/dl, P = 0.048, respectively). Bilirubin is inversely related to baPWV (R 2 = 0.0032, P = 0.003) and C-reactive protein (CRP) (correlation coefficient = −0.13, P < 0.001). A 0.1 mg/dl increase in bilirubin was associated with a 19, 20, and 34 % reduced odds ratio for baPWV above the 50th, 75th, and 95th percentiles, respectively [odds ratio (OR) 0.77 (95 % confidence interval (CI) 0.62–0.95), P = 0.015; OR 0.80 (95 % CI 0.64–0.99), P = 0.044; OR 0.68 (95 % CI 0.45–1.00), P = 0.048, respectively] after adjustment for several variables. This study demonstrates an independent inverse association between bilirubin and baPWV in hypertensive men. Additionally, reduced CRP may be one of mediators on the mechanisms how bilirubin reduces baPWV.
Literatur
1.
Zurück zum Zitat Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046PubMedCrossRef Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046PubMedCrossRef
2.
Zurück zum Zitat Stocker R, Glazer AN, Ames BN (1987) Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 84:5918–5922PubMedCrossRef Stocker R, Glazer AN, Ames BN (1987) Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 84:5918–5922PubMedCrossRef
3.
Zurück zum Zitat Stocker R, Peterhans E (1989) Antioxidant properties of conjugated bilirubin and biliverdin: biologically relevant scavenging of hypochlorous acid. Free Radic Res Commun 6:57–66PubMedCrossRef Stocker R, Peterhans E (1989) Antioxidant properties of conjugated bilirubin and biliverdin: biologically relevant scavenging of hypochlorous acid. Free Radic Res Commun 6:57–66PubMedCrossRef
4.
Zurück zum Zitat Wu TW, Fung KP, Wu J, Yang CC, Weisel RD (1996) Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 51:859–862PubMedCrossRef Wu TW, Fung KP, Wu J, Yang CC, Weisel RD (1996) Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 51:859–862PubMedCrossRef
5.
Zurück zum Zitat Minetti M, Mallozzi C, Di Stasi AM, Pietraforte D (1998) Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys 352:165–174PubMedCrossRef Minetti M, Mallozzi C, Di Stasi AM, Pietraforte D (1998) Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys 352:165–174PubMedCrossRef
6.
Zurück zum Zitat Baranano DE, Rao M, Ferris CD, Snyder SH (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99:16093–16098PubMedCrossRef Baranano DE, Rao M, Ferris CD, Snyder SH (2002) Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99:16093–16098PubMedCrossRef
7.
Zurück zum Zitat Pae HO, Oh GS, Lee BS, Rim JS, Kim YM, Chung HT (2006) 3-Hydroxyanthranilic acid, one of l-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. Atherosclerosis 187:274–284PubMedCrossRef Pae HO, Oh GS, Lee BS, Rim JS, Kim YM, Chung HT (2006) 3-Hydroxyanthranilic acid, one of l-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. Atherosclerosis 187:274–284PubMedCrossRef
8.
Zurück zum Zitat Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, Maruyama Y (2005) Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25:155–160PubMed Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, Maruyama Y (2005) Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25:155–160PubMed
10.
Zurück zum Zitat Leopold JA, Loscalzo J (2005) Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 25:1332–1340PubMedCrossRef Leopold JA, Loscalzo J (2005) Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 25:1332–1340PubMedCrossRef
11.
Zurück zum Zitat Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381–1478PubMedCrossRef Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381–1478PubMedCrossRef
12.
Zurück zum Zitat Schwertner HA, Jackson WG, Tolan G (1994) Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40:18–23PubMed Schwertner HA, Jackson WG, Tolan G (1994) Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40:18–23PubMed
13.
Zurück zum Zitat Perlstein TS, Pande RL, Beckman JA, Creager MA (2008) Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 28:166–172PubMedCrossRef Perlstein TS, Pande RL, Beckman JA, Creager MA (2008) Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 28:166–172PubMedCrossRef
14.
Zurück zum Zitat Matsuoka O, Otsuka K, Murakami S, Hotta N, Yamanaka G, Kubo Y, Yamanaka T, Shinagawa M, Nunoda S, Nishimura Y, Shibata K, Saitoh H, Nishinaga M, Ishine M, Wada T, Okumiya K, Matsubayashi K, Yano S, Ichihara K, Cornélissen G, Halberg F, Ozawa T (2005) Arterial stiffness independently predicts cardiovascular events in an elderly community-Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) Study. Biomed Pharmacother 59:S40–S44PubMedCrossRef Matsuoka O, Otsuka K, Murakami S, Hotta N, Yamanaka G, Kubo Y, Yamanaka T, Shinagawa M, Nunoda S, Nishimura Y, Shibata K, Saitoh H, Nishinaga M, Ishine M, Wada T, Okumiya K, Matsubayashi K, Yano S, Ichihara K, Cornélissen G, Halberg F, Ozawa T (2005) Arterial stiffness independently predicts cardiovascular events in an elderly community-Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) Study. Biomed Pharmacother 59:S40–S44PubMedCrossRef
15.
Zurück zum Zitat Song BG, Park JB, Cho SJ, Lee SY, Kim JH, Choi SM, Park JH, Park YH, Choi JO, Lee SC, Park SW (2009) Pulse wave velocity is more closely associated with cardiovascular risk than augmentation index in the relatively low-risk population. Heart Vessels 24:413–418PubMedCrossRef Song BG, Park JB, Cho SJ, Lee SY, Kim JH, Choi SM, Park JH, Park YH, Choi JO, Lee SC, Park SW (2009) Pulse wave velocity is more closely associated with cardiovascular risk than augmentation index in the relatively low-risk population. Heart Vessels 24:413–418PubMedCrossRef
16.
Zurück zum Zitat Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y (2002) Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25:359–364PubMedCrossRef Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y (2002) Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25:359–364PubMedCrossRef
17.
Zurück zum Zitat Hung CS, Lin JW, Hsu CN, Chen HM, Tsai RY, Chien YF, Hwang JJ (2009) Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks. Nutr Metab Cardiovasc Dis 19:241–246PubMedCrossRef Hung CS, Lin JW, Hsu CN, Chen HM, Tsai RY, Chien YF, Hwang JJ (2009) Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks. Nutr Metab Cardiovasc Dis 19:241–246PubMedCrossRef
18.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252
19.
Zurück zum Zitat Lawlor DA, Kim L, Morris R, Amuzu A, Whincup P, Ebrahim S (2011) Survival with treated and well-controlled blood pressure: findings from a prospective cohort study. PLoS ONE 6:e17792PubMedCrossRef Lawlor DA, Kim L, Morris R, Amuzu A, Whincup P, Ebrahim S (2011) Survival with treated and well-controlled blood pressure: findings from a prospective cohort study. PLoS ONE 6:e17792PubMedCrossRef
20.
Zurück zum Zitat Krantz MJ, Long CS, Hosokawa P, Karimkahani E, Dickinson M, Estacio RO, Masoudi FA, Havranek EP (2011) Pulse wave velocity and carotid atherosclerosis in White and Latino patients with hypertension. BMC Cardiovasc Disord 11:15PubMedCrossRef Krantz MJ, Long CS, Hosokawa P, Karimkahani E, Dickinson M, Estacio RO, Masoudi FA, Havranek EP (2011) Pulse wave velocity and carotid atherosclerosis in White and Latino patients with hypertension. BMC Cardiovasc Disord 11:15PubMedCrossRef
21.
Zurück zum Zitat Jae SY, Heffernan KS, Fernhall B, Oh YS, Park WH, Lee MK, Choi YH (2010) Association between cardiorespiratory fitness and arterial stiffness in men with the metabolic syndrome. Diabetes Res Clin Pract 90:326–332PubMedCrossRef Jae SY, Heffernan KS, Fernhall B, Oh YS, Park WH, Lee MK, Choi YH (2010) Association between cardiorespiratory fitness and arterial stiffness in men with the metabolic syndrome. Diabetes Res Clin Pract 90:326–332PubMedCrossRef
22.
Zurück zum Zitat National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266 National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266
23.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, the National High Blood Pressure Education Program Coordinating Committee (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413–2446 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, the National High Blood Pressure Education Program Coordinating Committee (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413–2446
24.
25.
Zurück zum Zitat Erdogan D, Gullu H, Yildirim E, Tok D, Kirbas I, Ciftci O, Baycan ST, Muderrisoglu H (2006) Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184:431–437PubMedCrossRef Erdogan D, Gullu H, Yildirim E, Tok D, Kirbas I, Ciftci O, Baycan ST, Muderrisoglu H (2006) Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184:431–437PubMedCrossRef
26.
Zurück zum Zitat Kim OY, Yoe HY, Kim HJ, Park JY, Kim JY, Lee SH, Lee JH, Lee KP, Jang Y, Lee JH (2010) Independent inverse relationship between serum lycopene concentration and arterial stiffness. Atherosclerosis 208:581–586PubMedCrossRef Kim OY, Yoe HY, Kim HJ, Park JY, Kim JY, Lee SH, Lee JH, Lee KP, Jang Y, Lee JH (2010) Independent inverse relationship between serum lycopene concentration and arterial stiffness. Atherosclerosis 208:581–586PubMedCrossRef
27.
Zurück zum Zitat Gullu H, Erdogan D, Tok D, Topcu S, Caliskan M, Ulus T, Muderrisoglu H (2005) High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions. Arterioscler Thromb Vasc Biol 25:2289–2294PubMedCrossRef Gullu H, Erdogan D, Tok D, Topcu S, Caliskan M, Ulus T, Muderrisoglu H (2005) High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions. Arterioscler Thromb Vasc Biol 25:2289–2294PubMedCrossRef
28.
Zurück zum Zitat Djousse L, Levy D, Cupples LA, Evans JC, D’Agostino RB, Ellison RC (2001) Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87:1196–1200PubMedCrossRef Djousse L, Levy D, Cupples LA, Evans JC, D’Agostino RB, Ellison RC (2001) Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 87:1196–1200PubMedCrossRef
29.
Zurück zum Zitat Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G (2001) Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 154:747–754PubMedCrossRef Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G (2001) Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 154:747–754PubMedCrossRef
30.
Zurück zum Zitat Oda E, Kawai R (2012) A possible cross-sectional association of serum total bilirubin with coronary heart disease and stroke in a Japanese health screening population. Heart Vessels 27:29–36PubMedCrossRef Oda E, Kawai R (2012) A possible cross-sectional association of serum total bilirubin with coronary heart disease and stroke in a Japanese health screening population. Heart Vessels 27:29–36PubMedCrossRef
31.
Zurück zum Zitat Li Y, Meng SY, Meng CC, Yu WG, Wang RT (2011) Decreased serum bilirubin is associated with arterial stiffness in men. Nutr Metab Cardiovasc Dis [Epub ahead of print]. PMID: 22118956 Li Y, Meng SY, Meng CC, Yu WG, Wang RT (2011) Decreased serum bilirubin is associated with arterial stiffness in men. Nutr Metab Cardiovasc Dis [Epub ahead of print]. PMID: 22118956
32.
Zurück zum Zitat Schwertner HA (1998) Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 136:383–387PubMedCrossRef Schwertner HA (1998) Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 136:383–387PubMedCrossRef
33.
Zurück zum Zitat Hoshida S, Miki T, Nakagawa T, Shinoda Y, Inoshiro N, Terada K, Adachi T (2011) Different effects of isoflavones on vascular function in premenopausal and postmenopausal smokers and nonsmokers: NYMPH study. Heart Vessels 26:590–595PubMedCrossRef Hoshida S, Miki T, Nakagawa T, Shinoda Y, Inoshiro N, Terada K, Adachi T (2011) Different effects of isoflavones on vascular function in premenopausal and postmenopausal smokers and nonsmokers: NYMPH study. Heart Vessels 26:590–595PubMedCrossRef
34.
Zurück zum Zitat Whitfield JB, Zhu G, Nestler JE, Heath AC, Martin NG (2002) Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. Clin Chem 48:1426–1431PubMed Whitfield JB, Zhu G, Nestler JE, Heath AC, Martin NG (2002) Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. Clin Chem 48:1426–1431PubMed
35.
Zurück zum Zitat Breimer LH, Wannamethee G, Ebrahim S, Shaper AG (1995) Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 41:1504–1508PubMed Breimer LH, Wannamethee G, Ebrahim S, Shaper AG (1995) Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 41:1504–1508PubMed
36.
Zurück zum Zitat Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR (1996) Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 16:250–255PubMedCrossRef Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR (1996) Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 16:250–255PubMedCrossRef
37.
Zurück zum Zitat Criqui MH, Ninomiya J (2006) The epidemiology of peripheral arterial disease. In: Creager MA, Dzau V, Loscalzo J (eds) Vascular medicine. Saunders Elsevier, Philadelphia Criqui MH, Ninomiya J (2006) The epidemiology of peripheral arterial disease. In: Creager MA, Dzau V, Loscalzo J (eds) Vascular medicine. Saunders Elsevier, Philadelphia
Metadaten
Titel
Serum total bilirubin is inversely associated with brachial-ankle pulse wave velocity in men with hypertension
verfasst von
Zheng-Yun Zhang
Lu-Qin Bian
Sae-Young Jae
Ji-Dong Sung
Yoon-Ho Choi
Publikationsdatum
01.07.2013
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 4/2013
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-012-0261-6

Weitere Artikel der Ausgabe 4/2013

Heart and Vessels 4/2013 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.